Post by luxetvox on Mar 11, 2024 20:27:34 GMT
I'm not sure if Bloomberg will be reporting the votes of other mutual fund complexes, but here's what just appeared in the Opko news feed. Strangely, Bloomberg does not even show Calvert as a stockholder (which iirc may also have been the case last year, or I vaguely remember something like this anyway*). My only question for Calvert: why the vote FOR and increase in the number of authorized shares?
*Edit: Think I've figured it out. Calvert is owned by Morgan Stanley, which owns 1,870,343 shares of Opko in different funds. Not a huge amount, BUT IT"S A START!
Calvert Backs Opko Health on 2 of 14 Proposals at March 28 AGM
2024-03-11 20:08:38.729 GMT
By Bloomberg Automation
(Bloomberg) -- Calvert Research and Management disclosed
its votes for Opko Health Inc.'s March 28 annual meeting on a
website managed by Institutional Shareholder Services Inc.
* Backing 2 of 14 Management Proposals
The firm voted as follows:
* Proposal 1.1 - Elect Director Phillip Frost
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 1.2 - Elect Director Jane H. Hsiao
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 1.3 - Elect Director Elias A. Zerhouni
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 1.4 - Elect Director Steven D. Rubin
** Filed by: Management
** Vote: Against
** Rationale: Director sits on the board at more than 4 public
companies.The board is not majority independent.
* Proposal 1.5 - Elect Director Gary J. Nabel
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 1.6 - Elect Director Richard M. Krasno
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 1.7 - Elect Director Prem A. Lachman
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 1.8 - Elect Director Roger J. Medel
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 1.9 - Elect Director John A. Paganelli
** Filed by: Management
** Vote: Against
** Rationale: The nominee is chair of the nominating committee
and the board comprises less than 40% representation of each
male and female.The board is not majority independent.Director
is not independent and sits on a key committee.
* Proposal 1.10 - Elect Director Richard C. Pfenniger, Jr.
** Filed by: Management
** Vote: Against
** Rationale: Director sits on the board at more than 4 public
companies.The board is not majority independent.
* Proposal 1.11 - Elect Director Alice Lin-Tsing Yu
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 2 - Increase Authorized Common Stock
** Filed by: Management
** Vote: For
** Rationale: A vote FOR this proposal is warranted given that
the size of the proposed increase in the number of authorized
shares of common stock is reasonable and there are no
substantial concerns about the company's past use of shares. (Calvert: are you high?)
* Proposal 3 - Advisory Vote to Ratify Named Executive Officers'
Compensation
** Filed by: Management
** Vote: Against
** Rationale: The company's long term incentive compensation is
not sufficiently tied to financial performance. (Calvert: you must have sobered up)
* Proposal 4 - Ratify Ernst & Young LLP as Auditors
** Filed by: Management
** Vote: For
** Rationale: In the absence of further concerns, a vote FOR is
warranted.
*Edit: Think I've figured it out. Calvert is owned by Morgan Stanley, which owns 1,870,343 shares of Opko in different funds. Not a huge amount, BUT IT"S A START!
Calvert Backs Opko Health on 2 of 14 Proposals at March 28 AGM
2024-03-11 20:08:38.729 GMT
By Bloomberg Automation
(Bloomberg) -- Calvert Research and Management disclosed
its votes for Opko Health Inc.'s March 28 annual meeting on a
website managed by Institutional Shareholder Services Inc.
* Backing 2 of 14 Management Proposals
The firm voted as follows:
* Proposal 1.1 - Elect Director Phillip Frost
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 1.2 - Elect Director Jane H. Hsiao
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 1.3 - Elect Director Elias A. Zerhouni
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 1.4 - Elect Director Steven D. Rubin
** Filed by: Management
** Vote: Against
** Rationale: Director sits on the board at more than 4 public
companies.The board is not majority independent.
* Proposal 1.5 - Elect Director Gary J. Nabel
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 1.6 - Elect Director Richard M. Krasno
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 1.7 - Elect Director Prem A. Lachman
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 1.8 - Elect Director Roger J. Medel
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 1.9 - Elect Director John A. Paganelli
** Filed by: Management
** Vote: Against
** Rationale: The nominee is chair of the nominating committee
and the board comprises less than 40% representation of each
male and female.The board is not majority independent.Director
is not independent and sits on a key committee.
* Proposal 1.10 - Elect Director Richard C. Pfenniger, Jr.
** Filed by: Management
** Vote: Against
** Rationale: Director sits on the board at more than 4 public
companies.The board is not majority independent.
* Proposal 1.11 - Elect Director Alice Lin-Tsing Yu
** Filed by: Management
** Vote: Against
** Rationale: The board is not majority independent.
* Proposal 2 - Increase Authorized Common Stock
** Filed by: Management
** Vote: For
** Rationale: A vote FOR this proposal is warranted given that
the size of the proposed increase in the number of authorized
shares of common stock is reasonable and there are no
substantial concerns about the company's past use of shares. (Calvert: are you high?)
* Proposal 3 - Advisory Vote to Ratify Named Executive Officers'
Compensation
** Filed by: Management
** Vote: Against
** Rationale: The company's long term incentive compensation is
not sufficiently tied to financial performance. (Calvert: you must have sobered up)
* Proposal 4 - Ratify Ernst & Young LLP as Auditors
** Filed by: Management
** Vote: For
** Rationale: In the absence of further concerns, a vote FOR is
warranted.